{"brief_title": "A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections", "brief_summary": "To compare the safety, tolerance and efficacy of fluconazole and amphotericin B as treatment for biopsy proven fungal infections in major organs, disseminated infection, suspected fungal infection and fungemia in adult neutropenic and non-neutropenic patients without AIDS, AIDS related complex (ARC), or extensive burns. HIV seropositive patients are allowed only if they also have a malignancy.", "condition": ["Mycoses", "HIV Infections"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Fluconazole", "Amphotericin B"], "criteria": "Inclusion Criteria Concurrent Medication: Allowed: - Immunostimulants under studies carried out under an IRB approved protocol. - Treatments of intercurrent non-fungal infection. - Allowed but requires monitoring during fluconazole therapy: - Barbiturates. - Phenytoin. - Oral hypoglycemics. - Coumarin-type anticoagulants. Patients must have the following: - Diagnosis or presumption of fungal infection under defined conditions. - Written informed consent either from the patient or the patient's legal guardian. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Burns > 30 percent of the body. - Diagnosis of AIDS or AIDS related complex (ARC). - HIV positive unless they have a malignancy. - History of allergy to or intolerance of imidazoles or azoles. - Moderate to severe liver disease as defined by specific lab values. - Unlikely to survive more than 24 hours. - Evidence of previous amphotericin B sensitivity. Concurrent Medication: Excluded: - Concomitant antifungal agents other than the study drugs. - Immunostimulants, except for studies carried out under an IRB approved protocol. Concurrent Treatment: Excluded: - Lymphocyte replacements. Patients with the following are excluded: - Defined disease conditions listed in Exclusion Co-Existing Conditions. - Unlikely to survive more than 24 hours. - Previous participation in this study; reentry for the same infection is not allowed. - Known to be unable to take amphotericin B due to acute toxicities. Prior Medication: Excluded: - Previous fluconazole therapy for this infection.", "gender": "All", "minimum_age": "13 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Amphotericin B", "mesh_term": ["Infection", "Communicable Diseases", "HIV Infections", "Mycoses", "Fluconazole", "Amphotericin B", "Liposomal amphotericin B"], "id": "NCT00002277"}